How to Buy Zoetis Stock
Zoetis Inc
Zoetis is a pharmaceutical company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker ZTS on the NYSE exchange.
Zoetis stock last closed at $149.56, up 2.76% from the previous day, and has decreased 15.19% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.06 percentage points. Zoetis stock is currently +3.29% from its 52-week low of $144.80, and -25.93% from its 52-week high of $201.92.
There are currently 457.87M shares of ZTS outstanding. The market cap of ZTS is $68.48B. In the past 24 hours, 4.07M ZTS shares were traded.
How to Buy Zoetis Stock
Wondering how to invest in Zoetis stock? Here's how.
- Decide where to buy Zoetis stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Zoetis stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Select your payment method and add your details.
- Research Zoetis stock: The Zoetis ticker symbol is ZTS. Is Zoetis stock a good investment? Should you buy shares of ZTS? How do ZTS's underlying business fundamentals look? Do top analysts think Zoetis is a good buy? Why has ZTS's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if ZTS is a good stock to buy).
- Make your ZTS buy order: Decide if you will purchase ZTS shares at the current market price or use a limit order to buy ZTS stock at a particular price.
- Get notifications regarding your investment in ZTS: Create a watchlist to key updates about your investment in Zoetis shares.
Step 1: Decide where to buy Zoetis stock
You will need a brokerage account to access the NYSE market and buy ZTS stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you can buy ZTS today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start a new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have created your account on the best app for stock investing, you can securely and quickly fund your account:
Watch the tutorial below if you need help transferring funds into your new investment account.
Step 4: Research Zoetis stock
After you have chosen the best place to buy Zoetis stock, it's absolutely critical to evaluate their stock prior to buying, so you can comprehend the risk as well as the opportunity.
Zoetis shares quick numbers
ZTS Overview
WallStreetZen was built to help everyday investors do better fundamental analysis.
You can view all of the due diligence checks on ZTS's stock page.
Is ZTS stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ZTS's intrinsic value.
Using relative valuations ratios:
- ZTS could be undervalued based on its P/E ratio of 29.44x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 46.85x
- ZTS may be overvalued based on its P/B ratio of 13.7x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.07x
- ZTS may be overvalued based on its PEG ratio of 2.3x
You can access additional valuation research on ZTS's stock here.
ZTS Financial Summary
Signs that ZTS is financially healthy:
- ZTS profit margin has gone up from 26.2% to 27.4% in the past year.
- There are more short-term assets than short-term liabilities on the ZTS balance sheet.
- Total ZTS debt is lower than 5 years ago, relative to shareholder equity.
- ZTS's operating cash flow of $2.35B allows it to safely service it's debt of $6.76B.
- ZTS earnings of $3.18B is not sufficient to cover its interest payments.
Signs that ZTS is not financially healthy:
- ZTS has a relatively high debt to equity ratio of 1.86.
- There are more long-term liabilities than short-term assets on the ZTS balance sheet.
Is Zoetis stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 5 Wall Street analysts who track ZTS, the consensus analyst rating on ZTS is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Zoetis stock forecast page.
ZTS Technical Indicators
ZTS Earnings
Last year, ZTS earnings were $2.34B. During the past five year, ZTS's earnings have increased by 11.41% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of -10.26%.
Last year, ZTS revenue was $8.54B. In the last 5 year, ZTS's revenue has increased by 7.96% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 31.07%.
Find out more about ZTS's earnings and revenue performance here.
Latest Insiders Trades at ZTS
Over the last 12 months, insiders at ZTS have sold more shares than they have bought.
Roxanne Lagano, Executive Vice President of ZTS, was the latest ZTS insider to sell. They sold $139,529.91 worth of ZTS shares on Apr 18, 2024.
Get more info about who owns ZTS stock here.
Does ZTS provide a stable income stream?
Zoetis pays a dividend of 1.08%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 3.58%. If you owned $1,000 of ZTS stock, you would have been paid $10.79 last year.
Zoetis dividend payments have consistently grown over the past decade and have remained stable.
Dig into more info about Zoetis dividend yield and history here.
Get opinions from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your ZTS buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, place a limit order.
Click the Open Trade button and eToro will place the order.
If you need more info about buying stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in ZTS
Now that you own some ZTS stock, you'll want to stay up-to-date on your new investment.
Add ZTS to a watchlist to track the latest developments regarding your ZTS stock.
ZTS Feed
How to Buy Stock in Zoetis
To reiterate, here are the 6 steps you need to take to buy Zoetis stock right now:
- Decide where to buy Zoetis stock
- Sign up for your brokerage account
- Deposit money your investment account
- Research Zoetis stock
- Make your ZTS buy order
- Get notifications regarding your investment in ZTS
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Zoetis, create a watchlist today.
More Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.